Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00478959
Status:
COMPLETED
Last Update Posted:
2020-09-18
First Post:
2007-05-24
Brief Title:
Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkins Lymphoma
Sponsor:
Organization:
University Health Network Toronto